延迟的培养转换预测乌干达的异尼胺单抗结核病的不良结果:从2017年至2022年的回顾性横截面研究
Joel Kabugo1,2, Obondo James Sande3, Jupiter Marina Kabahita4
1The WHO Supranational Tuberculosis Reference Laboratory, Ministry of Health, Kampala, Uganda. ksolomonjoel@gmail.com.
BMC infectious diseases
|July 2, 2025
概括
耐异酸结核病 (TB) 与较慢的培养转化有关. 及时对异化和利芬素耐药性的分子测试对于更好的结核病治疗结果和减少失败至关重要.
科学领域:
- 医学微生物学 医学微生物学
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 耐伊索尼亚,易受里芬素治疗的结核病 (TB) 影响了大量的新发病例和以前接受过治疗的病例.
- 目前对异化剂单抗结核病 (Hr-TB) 的治疗指南已经存在,但替代方案的有效性需要进一步研究.
- 及时识别Hr-TB患者对于改善治疗成功和减轻进一步耐药性的发展至关重要.
研究的目的:
- 为了确定乌干达的异化单抗结核病患者的治疗结果.
- 确定与这种患者群体治疗成功相关的因素.
主要方法:
- 从2017年3月到2022年3月,在乌干达进行了一项涉及新诊断和再治疗结核病患者的横截面研究,该研究涉及2017年3月至2022年3月的结核病患者.
- 现型药物敏感性测试 (DST) 确定了异化单抗性,通过分子测试 (线索探测) 检测特定突变 (InhA,KatG).
- 从实验室记录和治疗记录中收集了有关患者人口统计,治疗方案,不良反应和治疗结果的数据.
主要成果:
- 分析了85种异化物单抗分离物,其中大多数患者是新诊断的 (41.2%).
- 大多数参与者 (42.3%) 在治疗一个月后实现了文化消极性.
- 最常见的突变是在KatG MUT1区域 (S315T1);在不同年龄组之间没有观察到治疗结果的显著差异,尽管36岁以上的患者的死亡率更高.
结论:
- 异化单抗与两个月以上的延迟培养转换有关.
- 这项研究强调了对异化和利芬素耐药性的快速临床分子诊断的必要性.
- 实施及时测试可以提高结核病治疗结果,减少治疗失败.
相关概念视频
Pulmonary Tuberculosis V
246
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
246
Pulmonary Tuberculosis I
332
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
332
Pulmonary Tuberculosis IV
207
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
207
Pulmonary Tuberculosis II
381
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
381
Pulmonary Tuberculosis III
452
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
452
Development of Antibiotic Resistance
220
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
220


